Neumora holds routine annual meeting, elects three directors through 2029

Filed May 29, 2026 · Period ending May 27, 2026 · ~1 min read

Key Changes

• low

  Stockholders elected Paul L. Berns, Matthew Fust, and David Piacquad as Class III directors to serve three-year terms until the 2029 annual meeting, each receiving over 125 million votes in support.

  Item 5.07 verify on EDGAR →
• low

  Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 157.6 million votes for and only 53,613 against, continuing the firm's engagement.

  Item 5.07 verify on EDGAR →
• low

  Shareholders voted to hold executive compensation advisory votes annually rather than every two or three years, with 124.7 million votes supporting annual frequency.

  Item 5.07 verify on EDGAR →